Improving participation in colorectal cancer screening: A randomised controlled trial of sequential offers of faecal then blood based non-invasive tests

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 18, 2016, Pages 8455-8460

  Symonds, Erin L ^a,b   Pedersen, Susanne ^c   Cole, Stephen R ^a,b   Massolino, Joseph ^d   Byrne, Daniel ^e   Guy, John ^f   Backhouse, Patricia ^d   Fraser, Robert J ^a,g   LaPointe, Lawrence ^c   Young, Graeme P ^a  

^a FLINDERS UNIVERSITY   (Australia)

^b ANZAC Research Institute   (Australia)

^c Clinical Genomics Pty Ltd   (Australia)

^d East Adelaide Healthcare   (Australia)

^e Chandlers Hill Surgery   (Australia)

^f FlagstaffHill Medical Centre   (Australia)

^g FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

Colorectal cancer; Faecal immunochemical test; FOBT; Methylated blood test; Participation; Screening

Indexed keywords

AGED; CHEMISTRY; COLONOSCOPY; COLORECTAL NEOPLASMS; COMMUNITY PARTICIPATION; CONTROLLED STUDY; DIAGNOSTIC TEST; EARLY CANCER DIAGNOSIS; FECES; FEMALE; FOLLOW UP; HUMAN; IMMUNOCHEMISTRY; MALE; MIDDLE AGED; OCCULT BLOOD; PROCEDURES; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; STATISTICS AND NUMERICAL DATA; UTILIZATION;

AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; COMMUNITY PARTICIPATION; DIAGNOSTIC TESTS, ROUTINE; EARLY DETECTION OF CANCER; FECES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOCHEMISTRY; MALE; MIDDLE AGED; OCCULT BLOOD; PROGNOSIS;

EID: 84954285246     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.18.8455     Document Type: Article

References (27)

1. Adler A, Geiger S, Keil A, et al (2014). Improving compliance to colorectal cancer screening using blood and stool based tests in patients refusing screening colonoscopy in Germany. BMC Gastroenterol, 14, 183.
2. AIHW 2014. National Bowel Cancer Screening Program monitoring report: 2012-13., Canberra, Australian Institute of Health and Welfare Canberra.
3. Benning TM, Dellaert BG, Dirksen CD, et al (2014). Preferences for potential innovations in non-invasive colorectal cancer screening: A labeled discrete choice experiment for a Dutch screening campaign. Acta Oncol, 53, 898-908.
4. Bresalier RS, Kopetz S, Brenner DE (2015). Blood-Based Tests for Colorectal Cancer Screening: Do They Threaten the Survival of the FIT Test? Dig Dis Sci, 60, 664-71.
5. Cole SR, Gregory T, Whibley A, et al (2012). Predictors of Re-participation in Faecal Occult Blood Test-Based Screening for Colorectal Cancer. Asian Pac J Cancer Prev, 13, 5989-94.
6. Cole SR, Tucker GR, Osborne JM, et al (2013). Shift to earlier stage at diagnosis as a consequence of the National Bowel Cancer Screening Program. Med J Aust, 198, 327-30.
7. Cole SR, Young GP, Byrne D, et al (2002). Participation in screening for colorectal cancer based on a faecal occult blood test is improved by endorsement by the primary care practitioner. J Med Screen, 9, 147-52.
8. Cole SR, Young GP, Esterman A, et al (2003). A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screen, 10, 117-22.
9. Cole SR, Zajac I, Gregory T, et al (2011). Psychosocial variables associated with colorectal cancer screening in South Australia. Int J Behav Med, 18, 302-9.
10. DeBourcy AC, Lichtenberger S, Felton S, et al (2008). Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening. J Gen Intern Med, 23, 169-74.
11. deVos T, Tetzner R, Model F, et al (2009). Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin Chem, 55, 1337-46.
12. Fox A, Tietze PH, Ramakrishnan K (2014). Anorectal conditions: hemorrhoids. FP Essent, 419, 11-9.
13. Greiner KA, James AS, Born W, et al (2005). Predictors of fecal occult blood test (FOBT) completion among low-income adults. Prev Med, 41, 676-84.
14. Hardcastle JD, Chamberlain JO, Robinson MH, et al (1996). Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet, 348, 1472-7.
15. Hol L, Kuipers EJ, van Ballegooijen M, et al (2012). Uptake of faecal immunochemical test screening among nonparticipants in a flexible sigmoidoscopy screening programme. Int J Cancer, 130, 2096-102.
16. Mandel JS, Bond JH, Church TR, et al (1993). Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med, 328, 1365-71.
17. Marshall DA, Johnson FR, Phillips KA, et al (2007). Measuring patient preferences for colorectal cancer screening using a choice-format survey. Value Health, 10, 415-30.
18. Miles A, Rainbow S, von Wagner C (2011). Cancer fatalism and poor self-rated health mediate the association between socioeconomic status and uptake of colorectal cancer screening in England. Cancer Epidemiol Biomarkers Prev, 20, 2132-40.
19. Mitchell SM, Ross JP, Drew HR, et al (2014). A panel of genes methylated with high frequency in colorectal cancer. BMC Cancer, 14.
20. Osborne J, Wilson C, Moore V, et al (2012). Sample preference for colorectal cancer screening tests: Blood or stool? OJPM, 2, 326-31.
21. Pedersen S, Symonds E, Baker R, et al (2015a). Evaluation of an assay for methylated BCAT1 and IKZF1 in plasma for detection of colorectal neoplasia. BMC Cancer, In press.
22. Pedersen SK, Baker RT, McEvoy A, et al (2015b). A two-gene blood test for methylated DNA sensitive for colorectal cancer. PLoS One, 10, 125041.
23. Senore C, Ederle A, Benazzato L, et al (2013). Offering people a choice for colorectal cancer screening. Gut, 62, 735-40.
24. Symonds E, Young G, Osborne J, et al (2015). Comparison of a methylated two-gene (BCAT1-IKZF1) blood test to FIT for detection of colorectal neoplasia. Gastroenterology, 148, 746.
25. van Dam L, Kuipers EJ, Steyerberg EW, et al (2013). The price of autonomy: should we offer individuals a choice of colorectal cancer screening strategies? Lancet Oncol, 14, 38-46.
26. Worthley DL, Cole SR, Esterman A, et al (2006). Screening for colorectal cancer by faecal occult blood test: why people choose to refuse. Intern Med J, 36, 607-10.
27. Zorzi M, Fedeli U, Schievano E, et al (2014). Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test. Gut.